Orthofix's spine fixation sales jump 17.1% in Q2 2017 — 7 highlights

Spinal Tech

Orthofix International reported its second quarter financial results for 2017.

Here are seven highlights:


1. The company saw net sales of $108.9 million, reflecting a 4.7 percent increase over the same period the year prior.


2. Biologic sales jumped 9.9 percent to $15.7 million, compared to the second quarter of 2016.


3. Orthofix's spine fixation sales hit $21.4 million, a 17.1 percent increase over the second quarter of 2016.


4. The company's gross profit increased to $85.8 million over the year prior.


5. Net income from continuing operations hit $4.7 million, or $0.26 per share.


6. Orthofix's EBITDA was $14 million in the second quarter of 2017, up from $2.6 million in the same period the year prior.


7. The company's cash and cash equivalents were $44.3 million as of June 30.


Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Podcast

Featured Whitepapers